发明名称 SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
摘要 Provided herein are diaminopyrimidyl Compounds having the following structures:;wherein X, L, R1, and R2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta.
申请公布号 US2016354374(A1) 申请公布日期 2016.12.08
申请号 US201615241232 申请日期 2016.08.19
申请人 Signal Pharmaceuticals, LLC 发明人 Papa Patrick;Cathers Brian Edwin;CALABRESE Andrew Antony;WHITEFIELD Brandon Wade;BENNETT Brydon;CASHION Daniel;MORTENSEN Deborah;HUANG Dehua;TORRES Eduardo;PARNES Jason;SAPIENZA John;HANSEN Joshua;LEFTHERIS Katerina;CORREA Matthew;DELGADO Maria Mercedes;RAHEJA Raj K.;BAHMANYAR Sogole;HEGDE Sayee;NORRIS Stephen;PLANTEVIN-KRENITSKY Veronique
分类号 A61K31/506;A61K31/5377;A61K31/505 主分类号 A61K31/506
代理机构 代理人
主权项 1. A method for the treatment or prevention of PKC-theta mediated disorder comprising administering to a subject in need thereof an effective amount of a compound of formula (I): or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein: X is CN or CF3; L is (C1-4 alkyl); R1 is substituted or unsubstituted heteroaryl; and R2 is substituted or unsubstituted cycloalkyl, wherein the PKC-theta mediated disorder is graft-versus-host disease, organ transplant rejection, psoriasis, Duchenne muscular dystrophy, rheumatoid arthritis, insulin resistance, myasthenia gravis, multiple sclerosis, colitis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, Sjogren syndrome, asthma, or lupus.
地址 San Diego CA US